Heart Benefits Included In Future Research For Tomatoes, Lycopene – Heinz
This article was originally published in The Tan Sheet
Executive Summary
Lack of validated biomarkers for prostate cancer was one of the "big problems" for H.J. Heinz during the submission process for its qualified health claim for lycopene in tomato products, according to its Global Nutrition director
You may also be interested in...
Lawsuit Will Question Supplement Exclusion From Lycopene/Cancer Claims
American Longevity will file a lawsuit against FDA no later than Dec. 9 in response to the agency's denial of qualified health claims tying lycopene-containing dietary supplements to cancer risk reduction
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement